Atlas Trials

Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers

Clinical trial NCT04725175 · COMPLETED

Trial details

NCT number
NCT04725175
Sponsor
Contineum Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2021-02-26
Primary completion
2021-09-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.